Teva bosses issue riposte to Mylan, praise takeover plan

Executives at Israeli drugmaker Teva (TEVA.TA) sent an open letter to takeover target Mylan (MYL.O) on Monday, saying they remain committed to a deal and reiterated that Teva's $40 billion takeover proposal would benefit shareholders of both firms. In the letter, addressed to Mylan executive founder Robert Coury, Teva CEO Erez Vigodman and Chairman Yitzhak Peterburg repeated that a combination would add value to both companies. The letter said Mylan had made "made grossly incorrect statements to mislead your stockholders and other stakeholders about us".

Teva bosses issue riposte to Mylan, praise takeover plan source: http://finance.yahoo.com/news/teva-bosses-issue-riposte-mylan-203358787.html